Impact of Current Regulations on Patients’ Timely Access to Drug-Diagnostics Clinical Trials & Case Study of a Newly Approved CDx for Qfitlia®
- Streamlining global clinical trials to meet regulatory demands depending on location
- Comparing IVDR and IDE
- FDA Approval of the Innovance® ATIII test as CDx for Qfitlia® (fitusiran) for Hemophilia patients